$MCK

Lau Michele sold $2.7M of MCK

Lau Michele (EVP and Chief Legal Officer) sold 3,550 shares of MCKESSON CORP (MCK) at $761.09 ($2.70M total) on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lau Michele
Published May 27, 2026, 6:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 6:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MCK
Neutral
high confidence
Mentioned
$MCK
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MCKNeutralLow
01

Why it matters

Because the trade is pre-scheduled, it is less likely to be a real-time signal about near-term fundamentals; expect muted market reaction absent other news.

02

Market read

Insider selling disclosure with 10b5-1 reduces catalyst value; likely limited trading impact for MCK.

03

What to watch

The sale size ($2.70M) and post-transaction holdings (3,247 shares) may be consistent with routine diversification rather than a thesis change.

Relevance 7/10Timing: Immediate (filed today) but informationally limited; more useful for monitoring insider activity trends than for catalysts.

Background

SEC Form 4 reports insider trades; this one is an open-market sale by McKesson’s EVP and Chief Legal Officer under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$MCKNeutralHigh confidence
Context

McKesson disclosed an EVP/Chief Legal Officer open-market sale of 3,550 shares ($2.70M) under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely noise unless accompanied by other fundamental news.

Evidence & confidence

The filing is a Form 4 insider transaction and explicitly states a pre-arranged 10b5-1 plan, which generally reduces interpretive value for near-term price direction.

Market effects

Minimal; this is company-specific insider liquidity/compensation activity with no stated operational or regulatory change.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still reflect internal caution; traders may watch for clustering of sales around specific events.

Key entities

  • MCKESSON CORP

    Subject of the Form 4 insider transaction disclosure.

  • Lau Michele

    EVP and Chief Legal Officer who sold 3,550 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MCKMedAI 8/10

McKesson Confirms Data Breach: 284M Records, $55M Demand

McKesson Corporation confirmed a data breach affecting its oncology and medical-surgical units, with 284M records allegedly stolen. The company filed an SEC report and faces a $55M ransom demand from hackers, ShinyHunters, by September 1, 2026. McKesson's CTO, Francisco Fraga, acknowledged the breach but downplayed its ongoing impact.

$MCKMed

McKesson copes with fallout from data theft extortion attack

McKesson, a major healthcare distributor, reported a cyberattack resulting in data theft and temporary service disruptions. The attack, claimed by ShinyHunters, occurred between Aug. 21-25. McKesson assured customers of operational continuity but faces a Sept. 1 ransom deadline. The company reported $403.4B in annual revenue.

$MCKMed

Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson

McKesson confirmed a data breach affecting its oncology and medical-surgical units, with hackers claiming to have stolen millions of patient records, including personal and health information. The ShinyHunters group demanded a $55 million ransom. McKesson reported intermittent service issues but stated it is operating normally. The breach is part of a recent trend of cyberattacks on healthcare companies.